90 related articles for article (PubMed ID: 16915261)
1. Cancer: off by a whisker.
Dennis C
Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
[No Abstract] [Full Text] [Related]
2. Catch of the day: zebrafish as a human cancer model.
Stoletov K; Klemke R
Oncogene; 2008 Jul; 27(33):4509-20. PubMed ID: 18372910
[TBL] [Abstract][Full Text] [Related]
3. Faithful companions: a proposal for neurooncology trials in pet dogs.
Kimmelman J; Nalbantoglu J
Cancer Res; 2007 May; 67(10):4541-4. PubMed ID: 17510377
[TBL] [Abstract][Full Text] [Related]
4. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
5. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
[TBL] [Abstract][Full Text] [Related]
6. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.
Rubio-Viqueira B; Hidalgo M
Clin Pharmacol Ther; 2009 Feb; 85(2):217-21. PubMed ID: 19005462
[No Abstract] [Full Text] [Related]
7. Development of chondrosarcoma animal models for assessment of adjuvant therapy.
Clark JC; Dass CR; Choong PF
ANZ J Surg; 2009 May; 79(5):327-36. PubMed ID: 19566512
[TBL] [Abstract][Full Text] [Related]
8. An antioxidant effect by acyclic retinoid suppresses liver tumor in mice.
Sakabe T; Tsuchiya H; Endo M; Tomita A; Ishii K; Gonda K; Murai R; Takubo K; Hoshikawa Y; Kurimasa A; Ishibashi N; Yanagida S; Shiota G
Biochem Pharmacol; 2007 May; 73(9):1405-11. PubMed ID: 17261273
[TBL] [Abstract][Full Text] [Related]
9. Validating cancer drug targets.
Benson JD; Chen YN; Cornell-Kennon SA; Dorsch M; Kim S; Leszczyniecka M; Sellers WR; Lengauer C
Nature; 2006 May; 441(7092):451-6. PubMed ID: 16724057
[TBL] [Abstract][Full Text] [Related]
10. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
12. Moving ahead with personalized mouse models.
Bender E
Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
[No Abstract] [Full Text] [Related]
13. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
[TBL] [Abstract][Full Text] [Related]
14. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
[TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model.
Ho YT; Yang JS; Lu CC; Chiang JH; Li TC; Lin JJ; Lai KC; Liao CL; Lin JG; Chung JG
Phytomedicine; 2009 Sep; 16(9):887-90. PubMed ID: 19303753
[TBL] [Abstract][Full Text] [Related]
16. A new generation of mouse models of cancer for translational research.
Abate-Shen C
Clin Cancer Res; 2006 Sep; 12(18):5274-6. PubMed ID: 17000659
[No Abstract] [Full Text] [Related]
17. Pathology of Ovarian Neoplasms in Genetically Modified Mice.
Nikitin AY; Connolly DC; Hamilton TC
Comp Med; 2004 Feb; 54(1):26-8. PubMed ID: 15382342
[No Abstract] [Full Text] [Related]
18. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
19. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse.
Starkey JR; Rebane AK; Drobizhev MA; Meng F; Gong A; Elliott A; McInnerney K; Spangler CW
Clin Cancer Res; 2008 Oct; 14(20):6564-73. PubMed ID: 18927297
[TBL] [Abstract][Full Text] [Related]
20. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
